Bicara Therapeutics CFO Executes Stock Sale via Rule 10b5-1 Plan
Hyep Ivan, the Chief Financial Officer of Bicara Therapeutics Inc. (NASDAQ:BCAX), has completed a sale of common stock totaling over $211,000. The transaction, which occurred on April 21, 2026, was executed under a pre-established Rule 10b5-1 trading plan that the CFO had adopted back in February 2025. This movement follows a period of significant …